ACUTAAS vs ANUHPHR: Stock Comparison

Acutaas Chemicals Limited vs Anuh Pharma Limited

Live data: 24 July 2026, 4:08 PM IST • Source: NSE and company filings

Acutaas Chemicals Limited is the larger company by market capitalisation. Acutaas Chemicals Limited shows a higher ROE, faster revenue growth and a higher ROCE, while Anuh Pharma Limited shows a lower P/E, a higher dividend yield and lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Acutaas Chemicals Limited and Anuh Pharma Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, ACUTAAS is more favourable on 9 of 13 scored metrics and ANUHPHR on 4These counts are context-free and are not an overall rating.

Key Differences

Market Cap
ACUTAAS is the larger company
₹26,810 Cr vs ₹793 Cr
P/E Ratio
ANUHPHR has a lower P/E
19.37x vs 69x
P/B Ratio
ANUHPHR has a lower P/B
2.26x vs 16.12x
EPS
ACUTAAS has higher earnings per share
₹34.93 vs ₹4.1
Dividend Yield
ANUHPHR has a higher dividend yield
1.87% vs 0.04%
Revenue Growth (TTM YoY)
ACUTAAS has faster revenue growth
40.3% vs 2%
EPS Growth (TTM YoY)
ACUTAAS has faster EPS growth
105.6% vs -6%
Qtr Sales Growth
ACUTAAS has stronger quarterly sales growth
40.3% vs 2.01%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricACUTAASANUHPHR
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricACUTAASANUHPHR
Live Price₹3,259.5₹79.07
Day Change-5.77%-0.48%
Volume12.43 L17,342
52-Week High₹3,740₹101.7
52-Week Low₹1,125₹67
Distance from 52W High-12.85%-22.25%

Valuation

MetricACUTAASANUHPHR
Market Cap₹26,810 Cr₹793 Cr
P/E Ratio69x19.37x
P/B Ratio16.12x2.26x
EPS₹34.93₹4.1
Book Value₹201.93₹35.28
Dividend Yield0.04%1.87%

Growth

MetricACUTAASANUHPHR
Revenue Growth (TTM YoY)40.3%2%
EPS Growth (TTM YoY)105.6%-6%
Qtr Sales Growth40.3%2.01%
Qtr Profit Growth111%-6.26%

Profitability & Leverage

MetricACUTAASANUHPHR
ROE24%12.1%
ROCE31.6%15.9%
Net Margin26.6%5.32%
Operating Margin35.9%8%
Debt to Equity0.02x0x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricACUTAASANUHPHR
Promoter Holding32.66%71.78% 0.02 pp
FII Holding21.61% 2.13 pp0.05% 0.05 pp
DII Holding19.56% 0.04 pp0%
Public Holding26.16% 2.08 pp28.16% 0.02 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Acutaas Chemicals Limited and Anuh Pharma Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.